Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by O. Ericson
Pdb54 - Estimated Events Avoided and Cost Offsets Associated With Using Canagliflozin to Treat Patients With Type Two Diabetes Mellitus (T2dm) With or at High Risk of Developing Cardiovascular Disease (Cvd) in England
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Psy98 - Cost-Effectiveness Analysis of Ferric Maltol Versus Ferric Carboxymaltose for the Treatment of Iron Deficiency Anaemia in Ibd Patients in Sweden and Finland
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Related publications
The CANVAS Program: Implications of Canagliflozin on Reducing Cardiovascular Risk in Patients With Type 2 Diabetes Mellitus
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Pdb73 - Indirect Cost-Effectiveness Analysis of Empagliflozin Compared to Canagliflozin for Patients With T2dm and Cardiovascular Disease in the Spanish National Health Service
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Canagliflozin Improves Risk Factors of Metabolic Syndrome in Patients With Type 2 Diabetes Mellitus and Metabolic Syndrome
Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
Internal Medicine
Pharmacology
Improving Blood Pressure Control in Patients With Diabetes Mellitus and High Cardiovascular Risk
International Journal of Hypertension
Internal Medicine
Canagliflozin Should Be Prescribed With Caution to Individuals With Type 2 Diabetes and High Risk of Amputation
Diabetologia
Internal Medicine
Endocrinology
Metabolism
Diabetes
Pharmacokinetics, Pharmacodynamics, and Safety of Canagliflozin in Japanese Patients With Type 2 Diabetes Mellitus
Advances in Therapy
Medicine
Pharmacology
Effect of Canagliflozin on Serum Uric Acid in Patients With Type 2 Diabetes Mellitus
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
Target Values of Cardiovascular Risk Factors Are Not Associated With All-Cause Mortality in Patients With Type 2 Diabetes Mellitus
PLoS ONE
Multidisciplinary
Risk of Major Cardiovascular Events in Patients With Type 2 Diabetes With and Without Prior Cardiovascular Events: Results From the Leader Trial
Canadian Journal of Cardiology
Cardiovascular Medicine
Cardiology
